{"generic":"Technetium Tc 99m Succimer","drugs":["MPI DMSA","Technetium Tc 99m Succimer"],"mono":{"0":{"id":"925118-s-0","title":"Generic Names","mono":"Technetium Tc 99m Succimer"},"1":{"id":"925118-s-1","title":"Dosing and Indications","sub":{"0":{"id":"925118-s-1-4","title":"Adult Dosing","mono":"<b>Renal isotope studies, Of Renal Parenchymal Disorders:<\/b> 74 to 222 megabecquerels (2 to 6 millicuries) slow IV INJECTION between 10 minutes and 4 hours following preparation for an average patient (70 kg); renal images may be obtained 1 to 2 hours after injection "},"2":{"id":"925118-s-1-6","title":"Dose Adjustments","mono":"<ul><li><b>renal failure, advance:<\/b> may exhibit poor renal intake of technetium Tc 99m succimer; however, reports of satisfactory images have been obtained in some patients upon delaying imaging for up to 24 hours<\/li><li><b>geriatric:<\/b> start at the low end of the dosing range<\/li><\/ul>"},"3":{"id":"925118-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Renal isotope studies, Of Renal Parenchymal Disorders<br\/>"}}},"3":{"id":"925118-s-3","title":"Contraindications\/Warnings","sub":[{"id":"925118-s-3-9","title":"Contraindications","mono":"specific contraindications have not been determined <br\/>"},{"id":"925118-s-3-10","title":"Precautions","mono":"<ul><li>radiopharmaceutical, maintain adequate shielding and handle with care to minimize exposure to the patient and personnel<\/li><li>renal failure, advanced; poor renal uptake possible; delaying imaging for up to 24 hours may be required for satisfactory images<\/li><li>renal impairment; increased risk for toxicity; monitoring recommended<\/li><\/ul>"},{"id":"925118-s-3-11","title":"Pregnancy Category","mono":"<ul><li>C (FDA)<\/li><li>C (AUS)<\/li><\/ul>"},{"id":"925118-s-3-12","title":"Breast Feeding","mono":"<ul><li>AAP: Radioactive compounds that require temporary cessation of breastfeeding.<\/li><li>WHO: Avoid breastfeeding.<\/li><li>Micromedex: Milk effects are possible.<\/li><\/ul>"}]},"5":{"id":"925118-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Gastrointestinal:<\/b>Nausea<br\/>"},"6":{"id":"925118-s-6","title":"Drug Name Info","sub":{"0":{"id":"925118-s-6-17","title":"US Trade Names","mono":"MPI DMSA<br\/>"},"2":{"id":"925118-s-6-19","title":"Class","mono":"Diagnostic Agent, Radiopharmaceutical Imaging<br\/>"},"3":{"id":"925118-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"}}},"7":{"id":"925118-s-7","title":"Mechanism Of Action","mono":"Technetium Tc 99m succimer injection is a diagnostic radiopharmaceutical that is cleared renally, concentrating in the renal cortex, which allows radiographic imaging of the renal parenchyma.<br\/>"},"8":{"id":"925118-s-8","title":"Pharmacokinetics","sub":{"1":{"id":"925118-s-8-24","title":"Distribution","mono":"Protein binding, unknown extent <br\/>"},"3":{"id":"925118-s-8-26","title":"Excretion","mono":"Renal: extensive <br\/>"},"4":{"id":"925118-s-8-27","title":"Elimination Half Life","mono":"about 60 minutes <br\/>"}}},"9":{"id":"925118-s-9","title":"Administration","mono":"<b>General Information<\/b><br\/><ul><li>use waterproof gloves, effective radiation shielding, and appropriate safety measures during preparation and administration<\/li><li>place 1 of the vials in a suitable shielding container and swab the closure with a bacteriostatic swab<\/li><li> before reconstitution, the eluate may be adjusted to the correct radioactive concentration by dilution with preservative-free, nonbacteriostatic saline for injection.<\/li><li>using a 10-mL sterile syringe, inject an appropriate amount (not more than 1.4 gigabecquerels (40 millicuries) in a volume of 1 to 6 mL) of the eluate from a Tc 99m generator into the shielded vial; before removing the syringe from the vial, withdraw an equivalent volume of nitrogen from the space above the solution to normalize the pressure in the vial<\/li><li>carefully invert the vial a few times until the powder is completely dissolved<\/li><li>assay the total activity, complete the label provided and attach to the vial; if radiochemical purity is not adequate, discard the finished drug<\/li><li>incubate the vial for at least 10 minutes at room temperature<\/li><li>use the preparation between 10 minutes and 4 hours following reconstitution; discard any unused portion appropriately according to state or other regulations<\/li><li>administer technetium Tc 99m succimer by slow IV injection<\/li><\/ul>"},"10":{"id":"925118-s-10","title":"Monitoring","mono":"<ul><li>quality scintigraphic images are indicative of efficacy<\/li><li>renal function; especially in elderly and renally impaired patients<\/li><\/ul>"},"13":{"id":"925118-s-13","title":"Clinical Teaching","mono":"<ul><li>This drug may cause rare instances of syncope, fever, nausea, and maculopapular skin rash.<\/li><li>Instruct patient to notify their healthcare provider if they are breastfeeding or intend to breastfeed during or around the time of therapy; formula feedings are recommended.<\/li><\/ul>"}}}